Citation: Pa. Cohen et al., CHARACTERIZATION OF A NEW INTRABODY DIRECTED AGAINST THE N-TERMINAL REGION OF HUMAN P53, Oncogene, 17(19), 1998, pp. 2445-2456
Citation: R. Fahraeus et al., CHARACTERIZATION OF THE CYCLIN-DEPENDENT KINASE INHIBITORY DOMAIN OF THE INK4 FAMILY AS A MODEL FOR A SYNTHETIC TUMOR-SUPPRESSOR MOLECULE, Oncogene, 16(5), 1998, pp. 587-596
Authors:
WARBRICK E
HEATHERINGTON W
LANE DP
GLOVER DN
Citation: E. Warbrick et al., PCNA BINDING-PROTEINS IN DROSOPHILA-MELANOGASTER - THE ANALYSIS OF A CONSERVED PCNA BINDING DOMAIN, Nucleic acids research, 26(17), 1998, pp. 3925-3932
Citation: K. Lindner et al., EPITOPE MAPPING OF ANTIBODIES RECOGNIZING THE N-TERMINAL DOMAIN OF SIMIAN-VIRUS LARGE TUMOR-ANTIGEN, Intervirology, 41(1), 1998, pp. 10-16
Citation: S. Hansen et al., THE N-TERMINUS OF THE MURINE P53 TUMOR-SUPPRESSOR IS AN INDEPENDENT REGULATORY DOMAIN AFFECTING ACTIVATION AND THERMOSTABILITY, Journal of Molecular Biology, 275(4), 1998, pp. 575-588
Authors:
BOTTGER A
BOTTGER V
SPARKS A
LIU WL
HOWARD SF
LANE DP
Citation: A. Bottger et al., DESIGN OF A SYNTHETIC MDM2-BINDING MINI PROTEIN THAT ACTIVATES THE P53 RESPONSE IN-VIVO, Current biology, 7(11), 1997, pp. 860-869
Authors:
BALL KL
LAIN S
FAHRAEUS R
SMYTHE C
LANE DP
Citation: Kl. Ball et al., CELL-CYCLE ARREST AND INHIBITION OF CDK4 ACTIVITY BY SMALL PEPTIDES BASED ON THE CARBOXY-TERMINAL DOMAIN OF P21(WAF1), Current biology, 7(1), 1997, pp. 71-80
Citation: Ca. Midgley et Dp. Lane, P53 PROTEIN STABILITY IN TUMOR-CELLS IS NOT DETERMINED BY MUTATION BUT IS DEPENDENT ON MDM2 BINDING, Oncogene, 15(10), 1997, pp. 1179-1189
Citation: E. Warbrick et al., HOMOLOGOUS REGIONS OF FEN1 AND P21(CIP1) COMPETE FOR BINDING TO THE SAME SITE ON PCNA - A POTENTIAL MECHANISM TO COORDINATE DNA-REPLICATIONAND REPAIR, Oncogene, 14(19), 1997, pp. 2313-2321
Authors:
FAHRAEUS R
PARAMIO JM
BALL KL
LAIN S
LANE DP
Citation: R. Fahraeus et al., INHIBITION OF PRB PHOSPHORYLATION AND CELL-CYCLE PROGRESSION BY AN P16(INK4A) DERIVED SYNTHETIC PEPTIDE DESIGNED FOR INTRACELLULAR DELIVERY, Cancer gene therapy, 4(1), 1997, pp. 66-67
Authors:
BULLOCK AN
HENCKEL J
DEDECKER BS
JOHNSON CM
NIKOLOVA PV
PROCTOR MR
LANE DP
FERSHT AR
Citation: An. Bullock et al., THERMODYNAMIC STABILITY OF WILD-TYPE AND MUTANT P53 CORE DOMAIN, Proceedings of the National Academy of Sciences of the United Statesof America, 94(26), 1997, pp. 14338-14342
Citation: Tm. Bliss et Dp. Lane, KU SELECTIVELY TRANSFERS BETWEEN DNA-MOLECULES WITH HOMOLOGOUS ENDS, The Journal of biological chemistry, 272(9), 1997, pp. 5765-5773
Authors:
FOURIE AM
HUPP TR
LANE DP
SANG BC
BARBOSA MS
SAMBROOK JF
GETHING MJH
Citation: Am. Fourie et al., HSP70 BINDING-SITES IN THE TUMOR-SUPPRESSOR PROTEIN P53, The Journal of biological chemistry, 272(31), 1997, pp. 19471-19479
Authors:
FAHRAEUS R
PARAMIO JM
BALL KL
LAIN S
LANE DP
Citation: R. Fahraeus et al., INHIBITION OF PRB PHOSPHORYLATION AND CELL-CYCLE PROGRESSION BY A 20-RESIDUE PEPTIDE DERIVED FROM P16(CDKN2 INK4A)/, Current biology, 6(1), 1996, pp. 84-91
Citation: Sm. Picksley et al., THE P53-MDM2 INTERACTION IN A CANCER-PRONE FAMILY, AND THE IDENTIFICATION OF A NOVEL THERAPEUTIC TARGET, Acta oncologica, 35(4), 1996, pp. 429-434